- 29/12/2004 - Change of Directors' Interest Notices
- 23/12/2004 - Successful Completion of Share Purchase Plan
- 7/12/2004 - Positive Test Results for Anti-HIV Compound
- 2/12/2004 - Issue of Key Virion Patent
- 24/11/2004 - Biotron Share Purchase Plan
- 22/11/2004 - Biotron Share Purchase Plan
- 10/11/2004 - SARS Virus Treatment Target Identified
- 28/10/2004 - Successful Virion Project Toxicity Testing
- 22/10/2004 - Appendix 4C - Quarterly Report 30 Sept 2004
- 15/10/2004 - Resolutions passed at Annual General Meeting
- 15/10/2004 - Presentation to Annual General Meeting
- 6/10/2004 - Notice of change of interests of substantial holder
- 16/9/2004 - Notice of Annual General Meeting
- 30/8/2004 - Preliminary Final Report for year ended 30 June 2004
- 30/7/2004 - Share Price Fluctuation Query
- 15/7/2004 - Appendix 4C - Quarterly Report 30 June 2004
- 30/6/2004 - Annual Report for year ended 30 June 2004
- 23/6/2004 - Virion Project Toxicity Results
- 26/5/2004 - Operations Update
- 29/4/2004 - Appendix 4C - Quarterly report 31 March 2004
- 27/2/2004 - Half year financial report 31 December 2003
- 6/2/2004 - Shareholder update
- 14/1/2004 - $1.7 million Start grant for Clinical Development of HIV/AIDS Drugs
